| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/07/1994 | EP0613683A1 Pharmaceutical compositions for systemic administration of erythropoietin via the respiratory system |
| 09/07/1994 | EP0613476A1 3-pyridinol derivatives and their use as medicaments |
| 09/07/1994 | EP0613467A1 2-pyridinol derivatives and their use as medicaments |
| 09/07/1994 | EP0613377A1 Hemostatic composition for local hemostasis |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | CN1091746A Synthetic peptides derived from vitronectin and pharmaceutical compositions them |
| 09/07/1994 | CN1025853C Antithromotic compounds |
| 09/06/1994 | US5344957 Substituted β-amino acid derivatives useful as platelet aggregation inhibitors |
| 09/06/1994 | US5344918 Process for the manufacture of a high-purity activated factor VII concentrate essentially free of vitamin K-dependent factors and factors VIIIC and VIIICAg |
| 09/06/1994 | US5344915 Proteins and the preparation thereof |
| 09/06/1994 | US5344836 Fused benzeneoxyacetic acid derivatives |
| 09/06/1994 | US5344393 Use of synthetic oxygen carriers to facilitate oxygen delivery |
| 09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/01/1994 | WO1994019375A1 Iron-lactoferrin combination and process for producing the same |
| 09/01/1994 | WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/01/1994 | WO1994018991A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b) |
| 09/01/1994 | WO1994018981A1 Fibrinogen receptor antagonists |
| 09/01/1994 | WO1994014776A3 Bicyclic fibrinogen antagonists |
| 09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/01/1994 | CA2155515A1 Expansion of stem cells in long term bone marrow cultures by neutralization of tgf-.beta. |
| 09/01/1994 | CA2155123A1 Fibrinogen receptor antagonists |
| 08/31/1994 | EP0612846A1 G-CSF analog compositions and methods |
| 08/31/1994 | EP0612741A1 Cyclic derivatives, medicaments containing them and process for their preparation |
| 08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
| 08/31/1994 | EP0612315A1 Nitro compounds having vasodilator activity |
| 08/31/1994 | EP0612313A1 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 08/31/1994 | EP0612246A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/31/1994 | CN1091315A Fibrin sealant compositions and methods for utilizing same |
| 08/30/1994 | US5342953 N-2-chlorobenzyl-2-oxo and N-2-chlorobenzyl-2,2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno[3,2-c]pyridine derivatives therefrom |
| 08/30/1994 | US5342832 Administering to a human or an animal in the form of tablet, capsule or granules to prevent tissue damage, diabetes, trasplantation, cardiovascular and lipoprotein disorders |
| 08/30/1994 | US5342830 Antithrombosis agents |
| 08/30/1994 | CA1331757C 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| 08/25/1994 | DE4305388A1 Cyclic derivatives, medicaments containing these compounds and processes for their preparation |
| 08/25/1994 | CA2116181A1 Peptide derivatives of boronic acid, a process for their preparation and pharmaceutical compositions containing them |
| 08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
| 08/24/1994 | EP0611660A2 Condensed 5-membered heterocycles, process for their preparation and medicines containing these compounds |
| 08/24/1994 | EP0611376A1 Production and use of multimeric hemoglobins |
| 08/24/1994 | EP0358708B1 Blood substitutes |
| 08/23/1994 | US5340920 Physiologically active porcine peptide (CNP-53) |
| 08/23/1994 | US5340813 Substituted aminoalkyl xanthine compounds |
| 08/23/1994 | US5340727 GPIbα fragments and recombinant DNA expression vectors |
| 08/23/1994 | CA2116068A1 Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/21/1994 | CA2115967A1 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical, as inhibitors of the cellular na+/h+exchange or as a diagnostic, and pharmaceutical containing them |
| 08/19/1994 | CA2115815A1 Pharmaceutical compositions |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018216A1 N-alkyl-2-substituted atp analogues |
| 08/18/1994 | WO1994018215A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| 08/18/1994 | WO1994018200A1 Novel inhibitors of adenosine monophosphate deaminase |
| 08/18/1994 | WO1994018185A1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 08/18/1994 | WO1994017817A1 Inhibitors of thrombosis |
| 08/18/1994 | WO1994017784A1 Pulmonary administration of erythropoietin |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2154681A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| 08/18/1994 | CA2133761A1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 08/17/1994 | EP0610943A1 Pyridinium derivatives useful as PAF antagonists |
| 08/17/1994 | EP0610432A1 C8-cyclic peptidomimetics as fibrinogen antagonists |
| 08/17/1994 | EP0610334A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. |
| 08/17/1994 | EP0610246A1 Novel thrombin-inhibiting protein from ticks |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | CA2115737A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 08/16/1994 | US5338830 Cyclic peptides having diuretic and vasodilation activity |
| 08/16/1994 | US5338752 Substituted 2-imidazolone derivatives, their preparation and pharmaceutical compositions |
| 08/16/1994 | US5338677 Heparinase free of an anticoagulant component from flavobacterium Heparinum |
| 08/16/1994 | CA1331465C Sulphonoamide derivatives as thromboxane antagonists |
| 08/16/1994 | CA1331459C Sulfonyldecahydro-8h-isoquino-¬2,1-g|¬1,6|- naphthyridines, optical isomers thereof and related compounds |
| 08/12/1994 | CA2114183A1 Pyridinium derivatives |
| 08/10/1994 | EP0609293A1 Treatment of haemophilia |
| 08/10/1994 | EP0609282A1 Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 08/10/1994 | EP0609242A1 New thrombin-inhibiting protein isolated from ticks. |
| 08/10/1994 | CN1090575A Cyanoquanidines as k-channel blockers |
| 08/10/1994 | CN1090494A Bear bile powder enteric capsule and preparing technology |
| 08/10/1994 | CN1090493A Urinate assisting pharmaceutical |
| 08/09/1994 | US5336778 Substituted triazoles as angiotensin II antagonists |
| 08/09/1994 | US5336759 Biologically active peptide derived from frog (frog CNP) |
| 08/09/1994 | US5336620 Process for the production of an anticoagulant composition |
| 08/09/1994 | US5336496 Inhibitor for delta 5-desaturase |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
| 08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
| 08/04/1994 | WO1994017108A1 Anticoagulant composition |
| 08/04/1994 | WO1994017063A1 N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE 4H-IMIDAZO[4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS |
| 08/04/1994 | WO1994017034A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
| 08/04/1994 | WO1994016715A1 Selective cell proliferation |
| 08/04/1994 | CA2154787A1 Selective cell proliferation |
| 08/04/1994 | CA2154250A1 N,n'cyloalkyl/alkyl carboxamide 4h-imidazo[4,5-b]pyridine compounds as paf antagonists |
| 08/03/1994 | EP0608858A1 5-Membered heterocycles as aggregation inhibitors |
| 08/03/1994 | EP0608831A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608828A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608759A2 Piperazinderivatives |
| 08/03/1994 | EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES. |
| 08/03/1994 | EP0608260A1 Peptide inhibitors of inflammation mediated by selectins |
| 08/03/1994 | CN1090272A New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 08/03/1994 | CN1025563C A process for preparing an indan derivative |
| 08/02/1994 | US5334596 Anticoagulants |
| 08/02/1994 | US5334587 For adverse reactions from cancer chemotherapy, infections, cerebral dysfunction or fungal infection |
| 08/02/1994 | CA1331197C Enantiomeric glutaramide diuretic agents |
| 07/30/1994 | CA2114361A1 Piperazine derivatives |
| 07/27/1994 | EP0607775A2 Use of leflunomid for the inhibition of interleukin 1 beta |
| 07/27/1994 | EP0607374A1 Novel cyclic lipid derivatives as potent paf antagonists |